1.50 / AMA PRA Category 1 CreditTM 1.50 / CNE Contact Hour
Provided by the Annenberg Center for Health Sciences at Eisenhower
This activity is supported by an independent educational grant from Celgene.
This activity is supported by an independent educational grant from Novartis Pharmaceuticals Corporation.
Psoriatic arthritis (PsA) is a chronic, inflammatory, musculoskeletal, disabling disease, commonly associated with skin psoriasis, and estimated to affect up to 42% of the approximately 7.5 million people in the United States with psoriasis. There remains an ongoing challenge among clinicians to diagnose and treat patients, as well as to stay abreast of optimal treatment strategies. In this educational program, the latest biologic treatment recommendations are reviewed, as well as clinical trial results for novel emerging therapies.
This activity was developed for rheumatologists, dermatologists, primary care physicians, physician assistants, nurses, advanced nurse practitioners, and other health care providers who manage patients with psoriatic arthritis.
At the conclusion of this activity, participants should be better able to:
Describe the etiology and socioeconomic and psychosocial burden of PsA and the importance of early detection and treatment
Incorporate classification criteria into assessment of suspected PsA cases
Identify PsA-associated comorbidities, such as CVD, obesity, and IBD, as well as their implication on the choice of treatment options
Increase clinician communication to minimize differences in the assessment of PsA disease severity and to improve understanding of patient satisfaction with current treatment options
Apply an integrated approach to therapeutic intervention, incorporating patient-centric evidence and best practice recommendations for each treatment domain of PsA
Describe the mechanisms and latest safety and efficacy evidence for approved and emerging biologic and nonbiologic DMARDs for the treatment of patients with PsA
Conflict Of Interest Disclosure Policy
It is the policy of the Annenberg Center for Health Sciences to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.
The Annenberg Center for Health Sciences assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE/CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE/CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.
In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center for Health Sciences policy, the following disclosures have been made:
M. Elaine Husni, MD, MPH Vice Chair, Rheumatology Director, Arthritis and Musculoskeletal Center Cleveland Clinic Assistant Professor Cleveland Clinic Lerner College of Medicine Case Western Reserve University Cleveland, Ohio
Dr. Husni discloses the following: Consultant: Abbvie, Janssen, Lilly, Novartis, UCB
Joseph F. Merola, MD, MMSc Assistant Professor, Harvard Medical School Director, Clinical Unit for Research Innovation and Trials (CUReIT) Director, Center for Skin and Related Musculoskeletal Diseases Associate Program Director, Harvard Combined Internal Medicine-Dermatology Residency Training Program Brigham and Women’s Hospital Boston, Massachusetts
Dr. Merola discloses the following: Consultant: Abbvie, Celgene, Cowen Health Care, GlaxoSmithKline, Janssen, Lilly, Merck, Novartis, Sanofi/Regeneron, Sumumed, UCB Speaker Bureau: Abbvie
Publishing Staff Disclosures
Victoria Anderson (medical writer) has nothing to disclose. Heather Jimenez, FNP (nurse reviewer) has nothing to disclose. Kam Newman, MD (peer reviewer) has nothing to disclose.
AMA PRA Category 1 Credit(s)TM
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this live meeting for a maximum of 1.50 AMA PRA Category 1 CreditsTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Contact Hour(s)
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
A maximum of 1.50 contact hours may be earned for successful completion of this activity.
Provider is approved by the California Board of Registered Nursing, Provider #13664, for 1.50 contact hours.
Disclosure of Unlabeled Use
The faculty for this activity have disclosed that there will be no discussion about the use of products for non-FDA approved applications.
The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient’s unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.
This activity is an online enduring material. Successful completion is achieved by reading and/or viewing the material, reflecting on its implications for your practice, and completing the assessment component.
Please note: The content of this activity is housed on the website of our educational partner, Annenberg Center for Health Sciences at Eisenhower, and requires you to leave myCME and register on the Annenberg website.
Your certificate will be saved on the Annenberg website only and cannot be accessed in your myCME CME History. Please go to https://education.annenberg.net and sign in to access your certificate in the future.
For help or questions about this Internet activity, please contact Annenberg Continuing Education: email@example.com Annenberg Center for Health Sciences 39000 Bob Hope Drive Dinah Shore Building Rancho Mirage, CA 92270 Phone: 760-773-4500 Fax: 760-773-4513 8 AM – 5 PM, Pacific Time, Monday – Friday
Annenberg Center for Health Sciences respects your privacy. We don’t share information you give us, or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission. See Privacy Statement and other information at http://www.annenberg.net/privacy-policy/